J Cancer 2018; 9(17):3129-3137. doi:10.7150/jca.25376 This issue Cite

Review

Mesenchymal Stem Cell Derived Exosomes in Cancer Progression, Metastasis and Drug Delivery: A Comprehensive Review

Jingyi Zhou1*, Xiaohong Tan2*, Yiheng Tan1, Qiuyu Li1, Jianjun Ma1✉, Gangyang Wang3✉

1. Human Anatomy Laboratory, School of Basic Medicine, Xinxiang Medical University, Henan, 453003, China
2. The Third Affiliated Hospital of Xinxiang Medical University, Henan,453003, China
3. Department of Orthopaedics, Shanghai Bone Tumor Institute, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China
*These authors have contributed equally to this work

Citation:
Zhou J, Tan X, Tan Y, Li Q, Ma J, Wang G. Mesenchymal Stem Cell Derived Exosomes in Cancer Progression, Metastasis and Drug Delivery: A Comprehensive Review. J Cancer 2018; 9(17):3129-3137. doi:10.7150/jca.25376. https://www.jcancer.org/v09p3129.htm
Other styles

File import instruction

Abstract

With the development of cancer treatments, it has become a popular research focus that mesenchymal stem (or stromal) cells (MSCs) have the functional mechanisms that influence cancer progression. One of the underestimated mechanisms is secretion of highly specialized double-membrane structures called exosomes. Mesenchymal stem cells generate several exosomes that may act as paracrine mediators by exchanging genetic information. MSC-derived exosomes are microvesicles ranging from approximately 60-200 nm in size and detected in various body fluids. It has been demonstrated that MSC-derived exosomes are involved in tumor growth, angiogenesis, metastasis, and invasion. Furthermore, emerging evidence suggests that as natural nanocarriers, MSC-exosomes are responsible for multidrug resistance mechanisms, reverse effect of radiation injury, and immune regulation, which can be used in clinical applications for cancer therapy. The present review aims to briefly describe the properties and biological functions of MSC-exosomes in cancer progression and its possible clinical applications in the future.

Keywords: Mesenchymal stem cell, exosomes, cancer therapy


Citation styles

APA
Zhou, J., Tan, X., Tan, Y., Li, Q., Ma, J., Wang, G. (2018). Mesenchymal Stem Cell Derived Exosomes in Cancer Progression, Metastasis and Drug Delivery: A Comprehensive Review. Journal of Cancer, 9(17), 3129-3137. https://doi.org/10.7150/jca.25376.

ACS
Zhou, J.; Tan, X.; Tan, Y.; Li, Q.; Ma, J.; Wang, G. Mesenchymal Stem Cell Derived Exosomes in Cancer Progression, Metastasis and Drug Delivery: A Comprehensive Review. J. Cancer 2018, 9 (17), 3129-3137. DOI: 10.7150/jca.25376.

NLM
Zhou J, Tan X, Tan Y, Li Q, Ma J, Wang G. Mesenchymal Stem Cell Derived Exosomes in Cancer Progression, Metastasis and Drug Delivery: A Comprehensive Review. J Cancer 2018; 9(17):3129-3137. doi:10.7150/jca.25376. https://www.jcancer.org/v09p3129.htm

CSE
Zhou J, Tan X, Tan Y, Li Q, Ma J, Wang G. 2018. Mesenchymal Stem Cell Derived Exosomes in Cancer Progression, Metastasis and Drug Delivery: A Comprehensive Review. J Cancer. 9(17):3129-3137.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image